<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta http-equiv='content-language' content='en-us'>
<meta http-equiv="X-UA-Compatible" content="ie=edge">
<meta name="description" content="Simple Coronary Artery Disease (Cad) Antiplatelet Therapy References, Antiplatelet therapy in patients undergoing cabg e68. 10 however, despite antiplatelet therapy, ≈2% to 5% of cad and pad patients annually have major adverse cardiovascular events.
Management of Antiplatelet Therapy in Patients With Coronary Artery From ahajournals.org
Acute coronary syndrome (acs) is principally driven by platelet aggregation. Coronary artery disease (cad) is unresolved, and common practice is to add antiplatelet therapy to oral anticoagulation (oac). Antiplatelet therapy, and intensive statin therapy. Further studies are needed to investigate whether the.
">

<meta name="robots" content="index,follow">
<meta name="googlebot" content="index,follow">
<meta name="seznambot" content="index,follow" />
<meta name="Slurp" content="index,follow" />
<meta name="ia_archiver" content="index,follow" />
<meta name="Baiduspider" content="index,follow" />
<meta name="BecomeBot" content="index,follow" />
<meta name="Bingbot" content="index,follow" />
<meta name="btbot" content="index,follow" />
<meta name="Dotbot" content="index,follow" />
<meta name="Yeti" content="index,follow" />
<meta name="Teoma" content="index,follow" />
<meta name="Yandex" content="index,follow" />

    
<title>Simple Coronary Artery Disease (Cad) Antiplatelet Therapy References | Workout with Build Muscle</title>
<meta name="url" content="https://workoutcardio.github.io/build-muscle/coronary-artery-disease-cad-antiplatelet-therapy/" />
<meta property="og:url" content="https://workoutcardio.github.io/build-muscle/coronary-artery-disease-cad-antiplatelet-therapy/">
<meta property="article:author" content="David"> 
<meta name="author" content="David">
<meta name="geo.region" content="US">
<meta name="geo.region" content="GB">
<meta name="geo.region" content="CA">
<meta name="geo.region" content="AU">
<meta name="geo.region" content="IT">
<meta name="geo.region" content="NL">
<meta name="geo.region" content="DE">
<link rel="canonical" href="https://workoutcardio.github.io/build-muscle/coronary-artery-disease-cad-antiplatelet-therapy/">
<link rel="preconnect" href="https://stackpath.bootstrapcdn.com">
<link rel="dns-prefetch" href="https://stackpath.bootstrapcdn.com">
<link rel="preconnect" href="https://code.jquery.com">
<link rel="dns-prefetch" href="https://code.jquery.com">
<link rel="preconnect" href="https://i.pinimg.com">
<link rel="dns-prefetch" href="https://i.pinimg.com">
<link rel="preconnect" href="https://fonts.googleapis.com">
<link rel="dns-prefetch" href="https://fonts.googleapis.com">
<link rel="stylesheet" href="https://workoutcardio.github.io/assets/css/all.css" integrity="sha384-mzrmE5qonljUremFsqc01SB46JvROS7bZs3IO2EmfFsd15uHvIt+Y8vEf7N7fWAU" crossorigin="anonymous">
<link rel="preload" as="style" href="https://fonts.googleapis.com/css?family=Lora:400,400i,700">
<link href="https://fonts.googleapis.com/css?family=Lora:400,400i,700" rel="stylesheet">
<link rel="stylesheet" href="https://workoutcardio.github.io/assets/css/main.css">
<link rel="stylesheet" href="https://workoutcardio.github.io/assets/css/theme.css">
<link rel="icon" type="image/png" href="/logo.png">
<link rel="icon" type="image/x-icon" sizes="16x16 32x32" href="/favicon.ico">
<link rel="shortcut icon" href="/favicon.ico">


<script type="application/ld+json">
{
    "@context": "http://schema.org",
    "@type": "BlogPosting",
    "articleSection": "post",
    "name": "Simple Coronary Artery Disease (Cad) Antiplatelet Therapy References",
    "headline": "Simple Coronary Artery Disease (Cad) Antiplatelet Therapy References",
    "alternativeHeadline": "",
    "description": "Atherothrombosis is a pathophysiologic process that results in clinical ischemic events affecting the cerebral, coronary, and peripheral arterial circulation. Antiplatelet therapy, and intensive statin therapy.",
    "inLanguage": "en-us",
    "isFamilyFriendly": "true",
    "mainEntityOfPage": {
        "@type": "WebPage",
        "@id": "https:\/\/workoutcardio.github.io\/build-muscle\/coronary-artery-disease-cad-antiplatelet-therapy\/"
    },
    "author" : {
        "@type": "Person",
        "name": "David"
    },
    "creator" : {
        "@type": "Person",
        "name": "David"
    },
    "accountablePerson" : {
        "@type": "Person",
        "name": "David"
    },
    "copyrightHolder" : "Workout with Build Muscle",
    "copyrightYear" : "2022",
    "dateCreated": "2022-06-01T00:00:00.00Z",
    "datePublished": "2022-06-01T00:00:00.00Z",
    "dateModified": "2022-06-01T00:00:00.00Z",
    "publisher":{
        "@type":"Organization",
        "name": "Workout with Build Muscle",
        "url": "https://workoutcardio.github.io/build-muscle/",
        "logo": {
            "@type": "ImageObject",
            "url": "https:\/\/workoutcardio.github.io\/logo.png",
            "width":"32",
            "height":"32"
        }
    },
    "image": "https://workoutcardio.github.io/logo.png",
    "url" : "https:\/\/workoutcardio.github.io\/build-muscle\/coronary-artery-disease-cad-antiplatelet-therapy\/",
    "wordCount" : "2341",
    "genre" : [ "tricep extension" ],
    "keywords" : [ "Simple" , "Coronary" , "Artery" , "Disease" , "(Cad)" , "Antiplatelet" , "Therapy" , "References" ]
}
</script>

</head>
  <body>    
    <nav id="MagicMenu" class="topnav navbar navbar-expand-lg navbar-light bg-white fixed-top">
    <div class="container">
        <a class="navbar-brand" href="https://workoutcardio.github.io/build-muscle/"><span style="text-transform: capitalize;font-weight: bold;">Workout with Build Muscle</strong></a><button class="navbar-toggler collapsed" type="button" data-toggle="collapse" data-target="#navbarColor02" aria-controls="navbarColor02" aria-expanded="false" aria-label="Toggle navigation"><span class="navbar-toggler-icon"></span></button>
        <div class="navbar-collapse collapse" id="navbarColor02" style="">
            <ul class="navbar-nav mr-auto d-flex align-items-center">
               
               <li class="nav-item"><a class="nav-link" href="https://workoutcardio.github.io/contact/">Contact</a></li>
               <li class="nav-item"><a class="nav-link" href="https://workoutcardio.github.io/dmca/">Dmca</a></li>
               <li class="nav-item"><a class="nav-link" href="https://workoutcardio.github.io/privacy-policy/">Privacy Policy</a></li>
               <li class="nav-item"><a class="nav-link" href="https://workoutcardio.github.io/about/">About</a></li><li class="nav-item"><a class="nav-link" style="text-transform: capitalize;" href="https://workoutcardio.github.io/build-muscle/categories/cardio-workout/" title="Cardio Workout">Cardio Workout</a></li><li class="nav-item"><a class="nav-link" style="text-transform: capitalize;" href="https://workoutcardio.github.io/build-muscle/categories/workout-for-weight-loss/" title="Workout for Weight Loss">Workout for Weight Loss</a></li></ul>
        </div>
    </div>
    </nav>
    <main role="main" class="site-content">
<div class="container">
<div class="jumbotron jumbotron-fluid mb-3 pl-0 pt-0 pb-0 bg-white position-relative">
        <div class="h-100 tofront">
            <div class="row justify-content-between ">
                <div class=" col-md-6 pr-0 pr-md-4 pt-4 pb-4 align-self-center">
                    <p class="text-uppercase font-weight-bold"><span class="catlist"><a class="sscroll text-danger" href="https://workoutcardio.github.io/build-muscle/categories/cardio-workout"/>Cardio Workout</a> . </span></p>
                    <h1 class="display-4 mb-4 article-headline">Simple Coronary Artery Disease (Cad) Antiplatelet Therapy References</h1>
                    <div class="d-flex align-items-center">
                        <small class="ml-3">Written by David <span class="text-muted d-block mt-1">Jun 01, 2022 · <span class="reading-time">11 min read</span></span></small>
                    </div>
                </div>
                <div class="col-md-6 pr-0 align-self-center">
                    <img class="rounded" src="https://i2.wp.com/www.nps.org.au/assets/e0008c59de8dd486-ee136d075b40-Coronary-stent-shutterstock_731387407.jpg" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';" alt="Simple Coronary Artery Disease (Cad) Antiplatelet Therapy References"/>
                </div>
            </div>
        </div>
    </div>
</div>
<div class="container-lg pt-4 pb-4">
    <div class="row justify-content-center">
        <div class="col-md-12 col-lg-8">
            <article class="article-post">
            <p>Atherothrombosis is a pathophysiologic process that results in clinical ischemic events affecting the cerebral, coronary, and peripheral arterial circulation. Antiplatelet therapy, and intensive statin therapy.</p>
<center>
	
</center> 
<p><strong>Simple Coronary Artery Disease (Cad) Antiplatelet Therapy References</strong>, Antiplatelet therapy in patients undergoing cabg e68. 10 however, despite antiplatelet therapy, ≈2% to 5% of cad and pad patients annually have major adverse cardiovascular events.</p>
<p><img loading="lazy" width="100%" src="https://workoutcardio.github.io/img/placeholder.svg" data-src="https://i2.wp.com/www.ahajournals.org/cms/attachment/f3516b6e-c2c8-4266-98a5-a30c14a55eaa/2785fig02.jpeg" alt="Management of Antiplatelet Therapy in Patients With Coronary Artery" title="Management of Antiplatelet Therapy in Patients With Coronary Artery" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';" class="center" />
Management of Antiplatelet Therapy in Patients With Coronary Artery From ahajournals.org</p>
<p>Acute coronary syndrome (acs) is principally driven by platelet aggregation. Coronary artery disease (cad) is unresolved, and common practice is to add antiplatelet therapy to oral anticoagulation (oac). Antiplatelet therapy, and intensive statin therapy. Further studies are needed to investigate whether the.</p>
<h3 id="management-of-antiplatelet-therapy-in-patients-with-coronary-artery-beta-blockers-and-amiodarone-in-patients-undergoing-cabg-e69">Management of Antiplatelet Therapy in Patients With Coronary Artery Beta blockers and amiodarone in patients undergoing cabg e69.</h3><div class="d-block p-4">
	<center>
		<script type="text/javascript">
	atOptions = {
		'key' : '044478bac56eb613662b93ef204db084',
		'format' : 'iframe',
		'height' : 250,
		'width' : 300,
		'params' : {}
	};
	document.write('<scr' + 'ipt type="text/javascript" src="http' + (location.protocol === 'https:' ? 's' : '') + '://www.creativeformatsnetwork.com/044478bac56eb613662b93ef204db084/invoke.js"></scr' + 'ipt>');
		</script>	
	</center>
</div>
<p>Antiplatelet therapy in patients undergoing cabg e68. The choice and duration of antiplatelet therapy for secondary prevention of coronary artery disease (cad) is determined by the clinical context and treatment strategy. These recommendations are based on the european society of cardiology (esc) 2017 esc focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with eacts , the scottish dental clinical effectiveness programme (sdcep) management of dental patients taking anticoagulants or antiplatelet drugs [sdcep, 2015. Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease (cad) seen within a 12 month period who were prescribed aspirin or clopidogrel instructions:</p>
<p><img loading="lazy" width="100%" src="https://workoutcardio.github.io/img/placeholder.svg" data-src="https://i2.wp.com/openheart.bmj.com/content/openhrt/4/2/e000651/F2.large.jpg?width=800&amp;amp;height=600&amp;amp;carousel=1" alt="Dual antiplatelet therapy for secondary prevention of coronary artery" title="Dual antiplatelet therapy for secondary prevention of coronary artery" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';" class="center" />
<em>Source: openheart.bmj.com</em></p>
<p>Coronary artery disease (cad) is the most common cardiovascular disease, and it may manifest as a stable form or an acute coronary syndrome. Due to the aging of the population, the prevalence of this chronic disease is on the rise. The most common indications for oral anticoagulant are atrial fibrillation (af),. Acute coronary syndrome (acs) is principally driven by platelet aggregation. Dual antiplatelet therapy for secondary prevention of coronary artery.</p>
<p><img loading="lazy" width="100%" src="https://workoutcardio.github.io/img/placeholder.svg" data-src="https://i2.wp.com/jamanetwork.com/data/Journals/CARDIOLOGY/935739/hgs160003.pdf.gif" alt="Guideline Update on Duration of Dual Antiplatelet Therapy for CAD" title="Guideline Update on Duration of Dual Antiplatelet Therapy for CAD" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';" class="center" />
<em>Source: jamanetwork.com</em></p>
<p>Antiplatelet therapy in patients undergoing cabg e68. Antiplatelet agents, used alone or in combination, are effective in preventing recurrent vascular events among individuals with established vascular disease. Use of antiplatelet therapy has shown to reduce the occurrence of vascular events in patients with coronary artery disease, including myocardial infarction and death. All these patients were detected cyp2c19 genotype. Guideline Update on Duration of Dual Antiplatelet Therapy for CAD.</p>
<p><img loading="lazy" width="100%" src="https://workoutcardio.github.io/img/placeholder.svg" data-src="https://i2.wp.com/www.ahajournals.org/cms/attachment/dc460a65-532b-45fe-9c7e-5ad4c979ba50/1577fig01.jpg" alt="Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial" title="Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';" class="center" />
<em>Source: ahajournals.org</em></p>
<p>(1) prior af on anticoagulation and the need for pci; Pharmacotherapy in patients after revascularization e70. Coronary artery disease (cad) is to be approached with the most current treatment options and treated as a “condition.” recommendations are stated in. Older adults, especially females and people with diabetes. Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial.</p>
<p><img loading="lazy" width="100%" src="https://workoutcardio.github.io/img/placeholder.svg" data-src="https://i2.wp.com/www.ahajournals.org/cms/asset/944f5c49-20d1-48f2-bd60-cd342c8a3b07/e002301fig02.jpg" alt="Pretreatment With Antiplatelet Drugs in Invasively Managed Patients" title="Pretreatment With Antiplatelet Drugs in Invasively Managed Patients" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';" class="center" />
<em>Source: ahajournals.org</em></p>
<p>Antiplatelet agents, used alone or in combination, are effective in preventing recurrent vascular events among individuals with established vascular disease. Clinical pathways are suggested for four potential clinical situations: Due to the aging of the population, the prevalence of this chronic disease is on the rise. (1) prior af on anticoagulation and the need for pci; Pretreatment With Antiplatelet Drugs in Invasively Managed Patients.</p>
<p><img loading="lazy" width="100%" src="https://workoutcardio.github.io/img/placeholder.svg" data-src="https://i2.wp.com/www.nps.org.au/assets/57fc039e22450525-dc456458037c-figure-2-coronary.png" alt="Combining anticoagulation and antiplatelet drugs in coronary artery" title="Combining anticoagulation and antiplatelet drugs in coronary artery" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';" class="center" />
<em>Source: nps.org.au</em></p>
<p>10 however, despite antiplatelet therapy, ≈2% to 5% of cad and pad patients annually have major adverse cardiovascular events. Recognize patients with coronary artery disease (cad) for whom extended duration of dapt may be favored based on high ischemic risk. These recommendations are based on the european society of cardiology (esc) 2017 esc focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with eacts , the scottish dental clinical effectiveness programme (sdcep) management of dental patients taking anticoagulants or antiplatelet drugs [sdcep, 2015. Clinical pathways are suggested for four potential clinical situations: Combining anticoagulation and antiplatelet drugs in coronary artery.</p>
<p><img loading="lazy" width="100%" src="https://workoutcardio.github.io/img/placeholder.svg" data-src="https://i2.wp.com/openheart.bmj.com/content/openhrt/4/2/e000651/F1.large.jpg?width=800&amp;amp;height=600&amp;amp;carousel=1" alt="Dual antiplatelet therapy for secondary prevention of coronary artery" title="Dual antiplatelet therapy for secondary prevention of coronary artery" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';" class="center" />
<em>Source: openheart.bmj.com</em></p>
<p>Further studies are needed to investigate whether the. In order to prevent the development of related medical conditions, all people who have coronary artery disease (cad) are advised to take two types of medication: The newer antiplatelets ticagrelor and prasugrel have demonstrated superiority over clopidogrel. In patients with stable cad who have undergone elective percutaneous coronary intervention (pci), dual antiplatelet therapy is recommended for six to. Dual antiplatelet therapy for secondary prevention of coronary artery.</p>
<p><img loading="lazy" width="100%" src="https://workoutcardio.github.io/img/placeholder.svg" data-src="https://i2.wp.com/jama.jamanetwork.com/data/journals/jama/4948/jcr40037f2.gif" alt="Oral Antiplatelet Therapy in Cerebrovascular Disease, Coronary Artery" title="Oral Antiplatelet Therapy in Cerebrovascular Disease, Coronary Artery" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';" class="center" />
<em>Source: jama.jamanetwork.com</em></p>
<p>The following evidence statements are quoted verbatim from the referenced clinical guidelines. Coronary artery disease (cad) involves impairment of blood flow through the coronary arteries, most commonly by atheromas. Use of antiplatelet therapy has shown to reduce the occurrence of vascular events in patients with coronary artery disease, including myocardial infarction and death. The choice and duration of antiplatelet therapy for secondary prevention of coronary artery disease (cad) is determined by the clinical context and treatment strategy. Oral Antiplatelet Therapy in Cerebrovascular Disease, Coronary Artery.</p>
<p><img loading="lazy" width="100%" src="https://workoutcardio.github.io/img/placeholder.svg" data-src="https://i2.wp.com/jamanetwork.com/data/Journals/JAMA/4948/jcr40037f1.gif" alt="Oral Antiplatelet Therapy in Cerebrovascular Disease, Coronary Artery" title="Oral Antiplatelet Therapy in Cerebrovascular Disease, Coronary Artery" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';" class="center" />
<em>Source: jamanetwork.com</em></p>
<p>Conclusions—in af patients with stable cad, adding antiplatelet therapy on top of vka is not associated with a reduction in risk of recurrent coronary events or thromboembolism, while risk. Table 3 shows the associations between clinical characteristics and ctca findings with large/complex aaps. Dual antiplatelet therapy (dapt) has demonstrated a reduction in recurrent ischemic events. Clinical pathways are suggested for four potential clinical situations: Oral Antiplatelet Therapy in Cerebrovascular Disease, Coronary Artery.</p>
<p><img loading="lazy" width="100%" src="https://workoutcardio.github.io/img/placeholder.svg" data-src="https://i2.wp.com/heart.bmj.com/content/heartjnl/89/10/1273/F4.large.jpg?download=true" alt="Antiplatelet treatment in stable coronary artery disease Heart" title="Antiplatelet treatment in stable coronary artery disease Heart" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';" class="center" />
<em>Source: heart.bmj.com</em></p>
<p>Conclusions—in af patients with stable cad, adding antiplatelet therapy on top of vka is not associated with a reduction in risk of recurrent coronary events or thromboembolism, while risk. Pharmacotherapy in patients after revascularization e70. Antiplatelet therapy, and intensive statin therapy. Intensification of antiplatelet therapy, with the addition of a p2y 12 inhibitor to aspirin monotherapy, and prolongation of dapt, necessitate a fundamental tradeoff. Antiplatelet treatment in stable coronary artery disease Heart.</p>
<p><img loading="lazy" width="100%" src="https://workoutcardio.github.io/img/placeholder.svg" data-src="https://i2.wp.com/www.ahajournals.org/cms/attachment/e6320a13-57e3-4cc8-9a85-c9697ed291c7/10ga01.jpg" alt="Dual Anticoagulant and Antiplatelet Therapy for Coronary Artery Disease" title="Dual Anticoagulant and Antiplatelet Therapy for Coronary Artery Disease" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';" class="center" />
<em>Source: ahajournals.org</em></p>
<p>In order to prevent the development of related medical conditions, all people who have coronary artery disease (cad) are advised to take two types of medication: Various medications can relieve the symptoms and lower the risk of complications. The antiplatelet treatment was recorded according to the therapy actually adopted by the patients. Recognize patients with coronary artery disease (cad) for whom extended duration of dapt may be favored based on high ischemic risk. Dual Anticoagulant and Antiplatelet Therapy for Coronary Artery Disease.</p>
<p><img loading="lazy" width="100%" src="https://workoutcardio.github.io/img/placeholder.svg" data-src="https://i2.wp.com/jamanetwork.com/data/Journals/JAMA/4948/jcr40037t1.png" alt="Oral Antiplatelet Therapy in Cerebrovascular Disease, Coronary Artery" title="Oral Antiplatelet Therapy in Cerebrovascular Disease, Coronary Artery" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';" class="center" />
<em>Source: jamanetwork.com</em></p>
<p>Coronary artery disease (cad) is the most common cardiovascular disease, and it may manifest as a stable form or an acute coronary syndrome. Intensification of antiplatelet therapy, with the addition of a p2y 12 inhibitor to aspirin monotherapy, and prolongation of dapt, necessitate a fundamental tradeoff. Various medications can relieve the symptoms and lower the risk of complications. In order to prevent the development of related medical conditions, all people who have coronary artery disease (cad) are advised to take two types of medication: Oral Antiplatelet Therapy in Cerebrovascular Disease, Coronary Artery.</p>
<p><img loading="lazy" width="100%" src="https://workoutcardio.github.io/img/placeholder.svg" data-src="https://i2.wp.com/heart.bmj.com/content/heartjnl/103/11/871/F6.large.jpg?width=800&amp;amp;height=600&amp;amp;carousel=1" alt="Optimal duration of dual antiplatelet therapy after acute coronary" title="Optimal duration of dual antiplatelet therapy after acute coronary" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';" class="center" />
<em>Source: heart.bmj.com</em></p>
<p>Use of antiplatelet therapy has shown to reduce the occurrence of vascular events in patients with coronary artery disease, including myocardial infarction and death. The newer antiplatelets ticagrelor and prasugrel have demonstrated superiority over clopidogrel. Pharmacotherapy in patients after revascularization e70. A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: Optimal duration of dual antiplatelet therapy after acute coronary.</p>
<p><img loading="lazy" width="100%" src="https://workoutcardio.github.io/img/placeholder.svg" data-src="https://i2.wp.com/openheart.bmj.com/content/openhrt/4/2/e000651/F3.large.jpg" alt="Dual antiplatelet therapy for secondary prevention of coronary artery" title="Dual antiplatelet therapy for secondary prevention of coronary artery" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';" class="center" />
<em>Source: openheart.bmj.com</em></p>
<p>Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease (cad) seen within a 12 month period who were prescribed aspirin or clopidogrel instructions: Cacs, coronary artery calcium score. Acute coronary syndrome (acs) is principally driven by platelet aggregation. The following evidence statements are quoted verbatim from the referenced clinical guidelines. Dual antiplatelet therapy for secondary prevention of coronary artery.</p>
<p><img loading="lazy" width="100%" src="https://workoutcardio.github.io/img/placeholder.svg" data-src="https://i2.wp.com/heart.bmj.com/content/heartjnl/103/8/573/F3.large.jpg?width=800&amp;amp;height=600&amp;amp;carousel=1" alt="Duration of dual antiplatelet therapy in acute coronary syndrome Heart" title="Duration of dual antiplatelet therapy in acute coronary syndrome Heart" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';" class="center" />
<em>Source: heart.bmj.com</em></p>
<p>Dual antiplatelet therapy (dapt) has demonstrated a reduction in recurrent ischemic events. Cacs, coronary artery calcium score. The newer antiplatelets ticagrelor and prasugrel have demonstrated superiority over clopidogrel. Pharmacotherapy in patients after revascularization e70. Duration of dual antiplatelet therapy in acute coronary syndrome Heart.</p>
<p><img loading="lazy" width="100%" src="https://workoutcardio.github.io/img/placeholder.svg" data-src="https://i2.wp.com/www.nps.org.au/assets/004051571ce263fc-92ebf2bb6a82-figure-1-coronary.png" alt="Combining anticoagulation and antiplatelet drugs in coronary artery" title="Combining anticoagulation and antiplatelet drugs in coronary artery" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';" class="center" />
<em>Source: nps.org.au</em></p>
<p>3 the major complications in patients with af are. Beta blockers and amiodarone in patients undergoing cabg e69. Recognize patients with coronary artery disease (cad) for whom extended duration of dapt may be favored based on high ischemic risk. Older adults, especially females and people with diabetes. Combining anticoagulation and antiplatelet drugs in coronary artery.</p>
<p><img loading="lazy" width="100%" src="https://workoutcardio.github.io/img/placeholder.svg" data-src="https://i2.wp.com/heart.bmj.com/content/heartjnl/106/7/487/F2.large.jpg?download=true" alt="Coronary artery disease and acute coronary syndrome in women Heart" title="Coronary artery disease and acute coronary syndrome in women Heart" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';" class="center" />
<em>Source: heart.bmj.com</em></p>
<p>The recently published compass (cardiovascular outcomes for people using anticoagulation strategies) trial compared standard antiplatelet therapy with low‐dose aspirin (100 mg/day) vs rivaroxaban 2.5 mg twice daily plus aspirin or rivaroxaban 5 mg twice daily in 27 395 patients with stable coronary artery disease (cad) and/or pad. Coronary artery disease (cad) is to be approached with the most current treatment options and treated as a “condition.” recommendations are stated in. Chest pain, which might radiate to your left arm, shoulder, or neck. 9 the recommended treatment for patients with pad is single antiplatelet therapy. Coronary artery disease and acute coronary syndrome in women Heart.</p>
<p><img loading="lazy" width="100%" src="https://workoutcardio.github.io/img/placeholder.svg" data-src="https://i2.wp.com/openheart.bmj.com/content/openhrt/4/2/e000651/F4.large.jpg" alt="Dual antiplatelet therapy for secondary prevention of coronary artery" title="Dual antiplatelet therapy for secondary prevention of coronary artery" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';" class="center" />
<em>Source: openheart.bmj.com</em></p>
<p>Antiplatelet therapy in patients undergoing cabg e68. Especially after cessation of antiplatelet therapy. The choice and duration of antiplatelet therapy for secondary prevention of coronary artery disease (cad) is determined by the clinical context and treatment strategy. 9 the recommended treatment for patients with pad is single antiplatelet therapy. Dual antiplatelet therapy for secondary prevention of coronary artery.</p>
<p><img loading="lazy" width="100%" src="https://workoutcardio.github.io/img/placeholder.svg" data-src="https://i2.wp.com/www.escardio.org/static_file/Escardio/Medias/associations/european-association-for-cardiovascular-prevention-and-rehabilitation/CVD-programme/antiplatelets-figure2B.PNG?mts=1496737454766.PNG" alt="Cardio protective drugs Antiplatelets therapy" title="Cardio protective drugs Antiplatelets therapy" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';" class="center" />
<em>Source: escardio.org</em></p>
<p>(1) prior af on anticoagulation and the need for pci; In order to prevent the development of related medical conditions, all people who have coronary artery disease (cad) are advised to take two types of medication: The antiplatelet treatment was recorded according to the therapy actually adopted by the patients. Due to the aging of the population, the prevalence of this chronic disease is on the rise. Cardio protective drugs Antiplatelets therapy.</p>
<p><img loading="lazy" width="100%" src="https://workoutcardio.github.io/img/placeholder.svg" data-src="https://i2.wp.com/www.ahajournals.org/cms/attachment/f3516b6e-c2c8-4266-98a5-a30c14a55eaa/2785fig02.jpeg" alt="Management of Antiplatelet Therapy in Patients With Coronary Artery" title="Management of Antiplatelet Therapy in Patients With Coronary Artery" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';" class="center" />
<em>Source: ahajournals.org</em></p>
<p>These recommendations are based on the european society of cardiology (esc) 2017 esc focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with eacts , the scottish dental clinical effectiveness programme (sdcep) management of dental patients taking anticoagulants or antiplatelet drugs [sdcep, 2015. Atherothrombosis is a pathophysiologic process that results in clinical ischemic events affecting the cerebral, coronary, and peripheral arterial circulation. Coronary artery disease (cad) is unresolved, and common practice is to add antiplatelet therapy to oral anticoagulation (oac). Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease (cad) seen within a 12 month period who were prescribed aspirin or clopidogrel instructions: Management of Antiplatelet Therapy in Patients With Coronary Artery.</p>
<p><img loading="lazy" width="100%" src="https://workoutcardio.github.io/img/placeholder.svg" data-src="https://i2.wp.com/www.nps.org.au/assets/e0008c59de8dd486-ee136d075b40-Coronary-stent-shutterstock_731387407.jpg" alt="Combining anticoagulation and antiplatelet drugs in coronary artery" title="Combining anticoagulation and antiplatelet drugs in coronary artery" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';" class="center" />
<em>Source: nps.org.au</em></p>
<p>Due to the aging of the population, the prevalence of this chronic disease is on the rise. The choice and duration of antiplatelet therapy for secondary prevention of coronary artery disease (cad) is determined by the clinical context and treatment strategy. An impaired response to antiplatelet therapy has been consistently reported and. And (4) new or recurrent vte requiring. Combining anticoagulation and antiplatelet drugs in coronary artery.</p>
<p><img loading="lazy" width="100%" src="https://workoutcardio.github.io/img/placeholder.svg" data-src="https://i2.wp.com/heart.bmj.com/content/heartjnl/early/2021/01/26/heartjnl-2020-318045/F4.large.jpg?width=800&amp;amp;height=600&amp;amp;carousel=1" alt="Antiplatelet therapy in patients with myocardial infarction without" title="Antiplatelet therapy in patients with myocardial infarction without" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';" class="center" />
<em>Source: heart.bmj.com</em></p>
<p>Coronary artery disease (cad) is to be approached with the most current treatment options and treated as a “condition.” recommendations are stated in. 3 the major complications in patients with af are. And (4) new or recurrent vte requiring. Dual antiplatelet therapy (dapt) has demonstrated a reduction in recurrent ischemic events. Antiplatelet therapy in patients with myocardial infarction without.</p>
<p><img loading="lazy" width="100%" src="https://workoutcardio.github.io/img/placeholder.svg" data-src="https://i2.wp.com/bmjopen.bmj.com/content/bmjopen/4/10/e005781/F1.large.jpg" alt="Individualising dual antiplatelet therapy after percutaneous coronary" title="Individualising dual antiplatelet therapy after percutaneous coronary" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';" class="center" />
<em>Source: bmjopen.bmj.com</em></p>
<p>Intensification of antiplatelet therapy, with the addition of a p2y 12 inhibitor to aspirin monotherapy, and prolongation of dapt, necessitate a fundamental tradeoff. In order to prevent the development of related medical conditions, all people who have coronary artery disease (cad) are advised to take two types of medication: The following evidence statements are quoted verbatim from the referenced clinical guidelines. Some patients with coronary artery disease (cad) have indications for intense antiplatelet therapy and anticoagulant therapy. Individualising dual antiplatelet therapy after percutaneous coronary.</p>
<p><img loading="lazy" width="100%" src="https://workoutcardio.github.io/img/placeholder.svg" data-src="https://i2.wp.com/heart.bmj.com/content/heartjnl/early/2021/01/26/heartjnl-2020-318045/F1.large.jpg?width=800&amp;amp;height=600&amp;amp;carousel=1" alt="Antiplatelet therapy in patients with myocardial infarction without" title="Antiplatelet therapy in patients with myocardial infarction without" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';" class="center" />
<em>Source: heart.bmj.com</em></p>
<p>This measure is to be submitted a minimum of once per performance period for all patients with cad seen during the performance period. Pharmacotherapy in patients after revascularization e70. Beta blockers and amiodarone in patients undergoing cabg e69. Antiplatelet therapy in patients undergoing cabg e68. Antiplatelet therapy in patients with myocardial infarction without.</p>
<p><img loading="lazy" width="100%" src="https://workoutcardio.github.io/img/placeholder.svg" data-src="https://i2.wp.com/cdn.jamanetwork.com/ama/content_public/journal/jama/4948/jcr40037f3.gif?Expires=2147483647&amp;amp;Signature=lJSVhnZNlJIMkVBBs~v5jb1J6xUDgGju1eAqPOf1M-TULXt3HBYdpmaFz19R3rC6kBdzAkkyACDySvMkBm9iT5iI9GvxoUXg3xdLU3rSEAFU8sd-4U8qjJYttzKr3amx3A26JOV0ld8hiog1iONWLNrbAPZI~D6IbZBQkPEtbQ0HuhJ75iuJeH-vLIzHvQKNVBamuqhESrhT~tKn2dSIQc5c55t~Q8SD0nCOlKU7wbF8B6xichNU9XyDkLqJN8po3D33hcWEyB4z8IiOEjL3QHbhJs~6312XzWDmg55VF3Ultf~E7tTfvjL7H3T6tGfp6wPLFjBKNhvDclncCWDOXg__&amp;amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" alt="Oral Antiplatelet Therapy in Cerebrovascular Disease, Coronary Artery" title="Oral Antiplatelet Therapy in Cerebrovascular Disease, Coronary Artery" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';" class="center" />
<em>Source: jamanetwork.com</em></p>
<p>Pharmacotherapy in patients after revascularization e70. Beta blockers and amiodarone in patients undergoing cabg e69. Acute coronary syndrome (acs) is principally driven by platelet aggregation. Antiplatelet therapy in patients undergoing cabg e68. Oral Antiplatelet Therapy in Cerebrovascular Disease, Coronary Artery.</p>
<p><img loading="lazy" width="100%" src="https://workoutcardio.github.io/img/placeholder.svg" data-src="https://i2.wp.com/www.ahajournals.org/cms/attachment/c3aa26bf-93cb-4e32-9679-ae9842863a1c/jah33010-fig-0001.gif" alt="Management of Left Main Coronary Artery Disease Journal of the" title="Management of Left Main Coronary Artery Disease Journal of the" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';" class="center" />
<em>Source: ahajournals.org</em></p>
<p>Acute coronary syndrome (acs) is principally driven by platelet aggregation. 10.1093/eurheartj/ehn287 crossref medline google scholar; Coronary artery disease (cad) is the most common cardiovascular disease, and it may manifest as a stable form or an acute coronary syndrome. Use of antiplatelet therapy has shown to reduce the occurrence of vascular events in patients with coronary artery disease, including myocardial infarction and death. Management of Left Main Coronary Artery Disease Journal of the.</p>
<h3 id="antiplatelet-agents-used-alone-or-in-combination-are-effective-in-preventing-recurrent-vascular-events-among-individuals-with-established-vascular-disease">Antiplatelet Agents, Used Alone Or In Combination, Are Effective In Preventing Recurrent Vascular Events Among Individuals With Established Vascular Disease.</h3><p>Conclusions—in af patients with stable cad, adding antiplatelet therapy on top of vka is not associated with a reduction in risk of recurrent coronary events or thromboembolism, while risk. Atherothrombosis is a pathophysiologic process that results in clinical ischemic events affecting the cerebral, coronary, and peripheral arterial circulation. Table 3 shows the associations between clinical characteristics and ctca findings with large/complex aaps. Cacs, coronary artery calcium score.</p>
<h3 id="various-medications-can-relieve-the-symptoms-and-lower-the-risk-of-complications">Various Medications Can Relieve The Symptoms And Lower The Risk Of Complications.</h3><p>Antiplatelet therapy is part of the. Antiplatelet therapy in patients undergoing cabg e68. The most common indications for oral anticoagulant are atrial fibrillation (af),. 10.1093/eurheartj/ehn287 crossref medline google scholar;</p>
<h3 id="coronary-artery-disease-cad-is-unresolved-and-common-practice-is-to-add-antiplatelet-therapy-to-oral-anticoagulation-oac">Coronary Artery Disease (Cad) Is Unresolved, And Common Practice Is To Add Antiplatelet Therapy To Oral Anticoagulation (Oac).</h3><p>Antiplatelet therapy, and intensive statin therapy. Dual antiplatelet therapy (dapt) has demonstrated a reduction in recurrent ischemic events. Pharmacotherapy in patients after revascularization e70. Especially after cessation of antiplatelet therapy.</p>
<h3 id="and-4-new-or-recurrent-vte-requiring">And (4) New Or Recurrent Vte Requiring.</h3><p>Use of antiplatelet therapy has shown to reduce the occurrence of vascular events in patients with coronary artery disease, including myocardial infarction and death. In af patients with stable cad, the addition of antiplatelet therapy (either aspirin or clopidogrel) to vka therapy is not. 9 the recommended treatment for patients with pad is single antiplatelet therapy. 1,2 however, there are differences in the pathogenesis of thrombosis in af and cad.</p>

            </article>
            <div class="row"><div class="posts-image" style="width:50%;"><a style="margin:5px;" href="/build-muscle/will-working-out-30-min-a-day-help-me-lose-weight/">&laquo;&laquo;&nbsp;List Of Will Working Out 30 Min A Day Help Me Lose Weight For Weight Loss</a></div>
    <div class="posts-image" style="width:50%"><a style="margin:5px;" href="/build-muscle/what-are-the-high-intensity-workout/">Simple What Are The High Intensity Workout Ideas&nbsp;&raquo;&raquo;</a></div></div>
            
            <div class="mb-4">
                <span class="taglist"></span>
            </div>
        </div>
    </div>
</div>
<div class="container">
<div class="container pt-4 pb-4">
    
    <h5 class="font-weight-bold spanborder"><span>Related Article</span></h5>
    <div class="row">
        <div class="col-lg-6">
                <div class="mb-3 d-flex align-items-center">
                    <a href="/build-muscle/what-type-of-weightlifting-is-best-for-fat-loss/"><img height="80" src="/img/placeholder.svg" data-src="https://i.pinimg.com/originals/c0/91/58/c0915875e342d2a104792fa28e3c494b.jpg" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';"/></a>
                    <div class="pl-3">
                        <h2 class="mb-2 h6 font-weight-bold">
                        <a class="text-dark" href="/build-muscle/what-type-of-weightlifting-is-best-for-fat-loss/">Incredible What Type Of Weightlifting Is Best For Fat Loss For Diet</a>
                        </h2>
                        <small class="text-muted">Apr 21 . 9 min read</small>
                    </div>
                </div>
        </div>
        <div class="col-lg-6">
                <div class="mb-3 d-flex align-items-center">
                    <a href="/build-muscle/can-i-lose-belly-fat-by-doing-abs-workout/"><img height="80" src="/img/placeholder.svg" data-src="https://i.pinimg.com/originals/c7/51/78/c75178444cd954b1a5519af5274e7ad5.jpg" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';"/></a>
                    <div class="pl-3">
                        <h2 class="mb-2 h6 font-weight-bold">
                        <a class="text-dark" href="/build-muscle/can-i-lose-belly-fat-by-doing-abs-workout/">30 Min Can I Lose Belly Fat By Doing Abs Workout For Man</a>
                        </h2>
                        <small class="text-muted">Dec 22 . 11 min read</small>
                    </div>
                </div>
        </div>
        <div class="col-lg-6">
                <div class="mb-3 d-flex align-items-center">
                    <a href="/build-muscle/easy-back-workouts-without-weights/"><img height="80" src="/img/placeholder.svg" data-src="https://i.pinimg.com/originals/10/b4/17/10b417f928d5e76f7b148a8c7b4cf6d3.jpg" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';"/></a>
                    <div class="pl-3">
                        <h2 class="mb-2 h6 font-weight-bold">
                        <a class="text-dark" href="/build-muscle/easy-back-workouts-without-weights/">Free Easy Back Workouts Without Weights Ideas</a>
                        </h2>
                        <small class="text-muted">Jan 08 . 10 min read</small>
                    </div>
                </div>
        </div>
        <div class="col-lg-6">
                <div class="mb-3 d-flex align-items-center">
                    <a href="/build-muscle/cardio-and-strength-exercises-at-home/"><img height="80" src="/img/placeholder.svg" data-src="https://i2.wp.com/www.trimmedandtoned.com/wp-content/uploads/2016/09/At-Home-Cardio-Workout-Graphic.jpg" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';"/></a>
                    <div class="pl-3">
                        <h2 class="mb-2 h6 font-weight-bold">
                        <a class="text-dark" href="/build-muscle/cardio-and-strength-exercises-at-home/">20 Min Cardio And Strength Exercises At Home For Girls</a>
                        </h2>
                        <small class="text-muted">Jan 20 . 9 min read</small>
                    </div>
                </div>
        </div>
        <div class="col-lg-6">
                <div class="mb-3 d-flex align-items-center">
                    <a href="/build-muscle/advantage-of-endurance-sports/"><img height="80" src="/img/placeholder.svg" data-src="https://i2.wp.com/img.aws.livestrongcdn.com/ls-1200x630/ds-photo/getty/article/106/88/484694120.jpg" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';"/></a>
                    <div class="pl-3">
                        <h2 class="mb-2 h6 font-weight-bold">
                        <a class="text-dark" href="/build-muscle/advantage-of-endurance-sports/">20 Min Advantage Of Endurance Sports For Weight Loss</a>
                        </h2>
                        <small class="text-muted">Feb 28 . 9 min read</small>
                    </div>
                </div>
        </div>
        <div class="col-lg-6">
                <div class="mb-3 d-flex align-items-center">
                    <a href="/build-muscle/how-does-physical-activity-affect-the-cardiovascular-system/"><img height="80" src="/img/placeholder.svg" data-src="https://i2.wp.com/www.knowbalance.com/storage/app/media/cvd.jpg" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';"/></a>
                    <div class="pl-3">
                        <h2 class="mb-2 h6 font-weight-bold">
                        <a class="text-dark" href="/build-muscle/how-does-physical-activity-affect-the-cardiovascular-system/">Incredible How Does Physical Activity Affect The Cardiovascular System For Adults</a>
                        </h2>
                        <small class="text-muted">Apr 28 . 11 min read</small>
                    </div>
                </div>
        </div>
        <div class="col-lg-6">
                <div class="mb-3 d-flex align-items-center">
                    <a href="/build-muscle/health-benefits-of-resistance-bands/"><img height="80" src="/img/placeholder.svg" data-src="https://i.pinimg.com/736x/54/ed/d9/54edd9a7c49a8abff610d1158b2e714b.jpg" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';"/></a>
                    <div class="pl-3">
                        <h2 class="mb-2 h6 font-weight-bold">
                        <a class="text-dark" href="/build-muscle/health-benefits-of-resistance-bands/">15 Min Health Benefits Of Resistance Bands Just Simple Step</a>
                        </h2>
                        <small class="text-muted">Jun 09 . 11 min read</small>
                    </div>
                </div>
        </div>
        <div class="col-lg-6">
                <div class="mb-3 d-flex align-items-center">
                    <a href="/build-muscle/can-you-lose-weight-using-exercise-bands/"><img height="80" src="/img/placeholder.svg" data-src="https://i.pinimg.com/736x/2b/17/d0/2b17d08a323bdc7f211a45d265118d04.jpg" onerror="this.onerror=null;this.src='https:\/\/workoutcardio.github.io\/img\/placeholder.svg';"/></a>
                    <div class="pl-3">
                        <h2 class="mb-2 h6 font-weight-bold">
                        <a class="text-dark" href="/build-muscle/can-you-lose-weight-using-exercise-bands/">30 Min Can You Lose Weight Using Exercise Bands For Weight Loss</a>
                        </h2>
                        <small class="text-muted">Dec 15 . 11 min read</small>
                    </div>
                </div>
        </div>
</div>
</div>
</div>
    </main>    <script async="async" src="https://code.jquery.com/jquery-3.3.1.min.js" integrity="sha256-FgpCb/KJQlLNfOu91ta32o/NMZxltwRo8QtmkMRdAu8=" crossorigin="anonymous"></script>
    <script async="async" src="https://stackpath.bootstrapcdn.com/bootstrap/4.2.1/js/bootstrap.min.js" integrity="sha384-B0UglyR+jN6CkvvICOB2joaf5I4l3gm9GU6Hc1og6Ls7i6U/mkkaduKaBhlAXv9k" crossorigin="anonymous"></script>
    <script async="async" src="https://workoutcardio.github.io/assets/js/theme.js"></script>
    <script>function init(){var imgDefer=document.getElementsByTagName('img');for (var i=0; i<imgDefer.length; i++){if(imgDefer[i].getAttribute('data-src')){imgDefer[i].setAttribute('src',imgDefer[i].getAttribute('data-src'));}}}window.onload=init;</script>
    
    <footer class="bg-white border-top p-3 text-muted small">
        <div class="container">
        <div class="row align-items-center justify-content-between">
            <div><span style="text-transform: capitalize;"><a href="https://workoutcardio.github.io/build-muscle/">Workout with Build Muscle</a> Copyright &copy; 2022.</span></div>
            
        </div>
        </div>
    </footer>

<script type="text/javascript">
var sc_project=12673169; 
var sc_invisible=1; 
var sc_security="7426f851"; 
</script>
<script type="text/javascript"
src="https://www.statcounter.com/counter/counter.js"
async></script>
<noscript><div class="statcounter"><a title="Web Analytics"
href="https://statcounter.com/" target="_blank"><img
class="statcounter"
src="https://c.statcounter.com/12673169/0/7426f851/1/"
alt="Web Analytics"
referrerPolicy="no-referrer-when-downgrade"></a></div></noscript>


  </body>
</html>